Non-Alcoholic Fatty Liver Disease

Introduction

Being told you have non-alcoholic fatty liver disease (NAFLD) can feel confusing. Many people first hear the diagnosis after a routine blood test, an ultrasound done for another reason, or a check-up for diabetes. Because the liver rarely complains until late, the news often arrives without obvious symptoms to match it.

NAFLD is now one of the most common liver conditions in the world. It is closely linked to weight, blood sugar, cholesterol, and overall metabolic health. The good news is that, especially in its earlier stages, the liver has a strong ability to heal. Many patients can stabilise the condition — and some can reverse it — with steady changes to lifestyle, careful management of related conditions, and regular follow-up.

This guide explains what NAFLD is, how doctors stage and treat it, what to expect during long-term management, and how care changes as the disease progresses. It is written for people who already have a diagnosis or are being investigated for one, and for family members supporting them.

What Is Non-Alcoholic Fatty Liver Disease?

Non-alcoholic fatty liver disease (NAFLD) is a condition in which excess fat builds up inside liver cells in people who drink little or no alcohol. The liver normally contains a small amount of fat. When fat makes up more than about 5% of the liver’s weight, doctors call it steatosis, or fatty liver.

NAFLD is closely tied to the body’s metabolism. For this reason, in 2023 major liver societies including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) renamed the condition metabolic dysfunction-associated steatotic liver disease (MASLD). The older name NAFLD is still widely used, and you will see both terms in clinics. They refer to the same underlying condition.

• Simple fatty liver (steatosis): Fat is present in liver cells, but there is little or no inflammation. Most people at this stage feel well.
• Non-alcoholic steatohepatitis (NASH), now also called metabolic dysfunction-associated steatohepatitis (MASH): Fat is accompanied by inflammation and injury to liver cells. This is the form that can damage the liver over time.
• Fibrosis: Ongoing inflammation leads to scar tissue forming in the liver. Fibrosis is graded from F1 (mild) to F3 (advanced).
• Cirrhosis (F4): Widespread scarring stiffens the liver and begins to affect how it works.

Most people with NAFLD will never progress to advanced stages. A smaller proportion develop NASH/MASH, and within that group, a smaller proportion go on to develop significant fibrosis or cirrhosis over many years. The aim of management is to identify who is at risk of progression, slow or reverse damage where possible, and watch for complications in those with more advanced disease.

Causes and Risk Factors

NAFLD is not caused by alcohol. It develops when the body’s handling of fats and sugars goes off balance, and the liver becomes a storage site for extra fat. The biggest drivers are conditions that affect metabolism.

Main risk factors

• Overweight and obesity, especially fat carried around the abdomen
• Type 2 diabetes and prediabetes
• Insulin resistance, where the body’s cells respond less well to insulin
• High triglycerides and abnormal cholesterol
• High blood pressure
• Metabolic syndrome — a cluster of the above
• Polycystic ovary syndrome (PCOS)
• Obstructive sleep apnoea
• Hypothyroidism

Other contributing factors

• A diet high in refined sugars, fructose-sweetened drinks, and ultra-processed foods
• Sedentary lifestyle with little regular activity
• Rapid weight gain, or repeated cycles of weight loss and regain
• Family history of fatty liver, type 2 diabetes, or early heart disease
• Certain medicines used long-term (your doctor will review your list)
• South Asian ancestry, which is associated with a higher risk at lower body weights

Genetics also matter. Some people carry gene variants (such as in PNPLA3 or TM6SF2) that make the liver more likely to store fat or develop inflammation. This helps explain why some people with normal weight develop NAFLD, while others with significant weight do not.

Signs and Symptoms

NAFLD is often called a silent disease because most people have no symptoms in the early stages. The diagnosis frequently comes as a surprise — for example, after a routine ultrasound or slightly raised liver enzymes on a blood test.

When symptoms do appear, they tend to be vague:

• Persistent tiredness
• A dull discomfort or fullness in the upper right side of the abdomen
• Reduced stamina or feeling generally “run down”

Signs that may suggest progression

If NAFLD progresses to cirrhosis, the body begins to show signs that the liver is struggling. These signs are not specific to NAFLD — they appear in advanced liver disease of any cause — and they are reasons to contact your specialist promptly:

• Yellowing of the skin or the whites of the eyes (jaundice)
• Swelling of the abdomen (ascites) or the legs
• Easy bruising, frequent nosebleeds, or bleeding gums
• Confusion, drowsiness, or changes in sleep pattern
• Vomiting blood or passing black, tarry stools (urgent — seek emergency care)
• Unexplained, marked weight loss

Diagnosing NAFLD is not only about confirming that there is fat in the liver. It is also about staging — finding out whether there is inflammation, how much scarring is present, and whether other conditions are contributing. Staging guides everything that follows.

Initial assessment

Your doctor will usually start with:

• A detailed history including weight changes, diet, activity, medical conditions, medicines, family history, and alcohol intake (NAFLD is diagnosed when liver damage is not explained by significant alcohol use)
• Measurement of weight, height, waist size, and blood pressure
• Blood tests for liver enzymes (ALT, AST), full blood count, blood sugar (fasting glucose, HbA1c), cholesterol and triglycerides, kidney function, and tests to rule out other liver diseases such as viral hepatitis

Liver enzymes can be normal even when NAFLD is present, so normal results do not rule out the condition.

Imaging

• Ultrasound is often the first imaging test. It can detect fatty change but is less reliable for mild fat or for measuring scarring.
• FibroScan (transient elastography) is a quick, painless test that uses a probe on the skin to measure liver stiffness, which reflects fibrosis, and the controlled attenuation parameter (CAP) score, which reflects fat.
• MRI-based tests such as MRI proton density fat fraction (MRI-PDFF) and MR elastography give more precise measurements of fat and stiffness. They are widely used in specialist clinics and in clinical trials.

Non-invasive fibrosis scores

Major guidelines, including those from AASLD and the American Gastroenterological Association (AGA), recommend a stepwise approach. The first step is usually a simple blood-based score such as the FIB-4 index, calculated from age, AST, ALT, and platelet count. If the FIB-4 score is low, the risk of advanced fibrosis is also low and routine monitoring is appropriate. If the score is intermediate or high, further testing such as FibroScan or specialised blood markers (for example, the Enhanced Liver Fibrosis test) is used to clarify the picture.

Liver biopsy

A small sample of liver tissue, taken with a needle, remains the most detailed way to confirm NASH and to measure fibrosis. Because non-invasive tests have improved, biopsy is now used selectively — for example, when the diagnosis is uncertain, when other liver conditions might overlap with NAFLD, or before starting certain treatments.

Treatment and Management

The cornerstone of NAFLD care is treating the metabolic conditions that drive it. Lifestyle change comes first for almost everyone. Medication, procedures, and surgery are added when needed and when the stage of disease justifies them.

Weight loss as the foundation

Current AASLD and EASL guidance describes gradual weight loss as the single most effective treatment for most people with NAFLD. The amount of weight loss matters:

• Losing around 3–5% of body weight can reduce liver fat.
• Losing around 7–10% of body weight is associated with improvement in inflammation (NASH) and, in many cases, some reduction in fibrosis.

Rapid crash diets are not advised because very fast weight loss can sometimes worsen liver inflammation. The aim is steady loss over months, supported by realistic changes that can be maintained for years.

Controlling related conditions

Because NAFLD sits inside a wider picture of metabolic health, tight control of related conditions is central:

• Diabetes and prediabetes: good blood sugar control reduces the metabolic stress on the liver and lowers the risk of progression.
• Cholesterol and triglycerides: statins are generally safe in NAFLD and are commonly used to lower the risk of heart disease, which is the leading cause of death in people with NAFLD.
• Blood pressure: well-controlled blood pressure protects both the liver and the heart.
• Sleep apnoea: diagnosing and treating obstructive sleep apnoea may improve metabolic health.

Medications targeting NAFLD/NASH

For many years there was no medicine specifically approved for NAFLD. The landscape is now changing, and several classes of medicines are used or being studied:

• Vitamin E (alpha-tocopherol): guidelines suggest it may be considered for selected non-diabetic adults with biopsy-proven NASH, after discussion of benefits and possible risks.
• Pioglitazone: a diabetes medicine that has been shown to improve NASH in some patients, including some without diabetes. Doctors weigh its benefits against possible side effects such as weight gain and fluid retention.
• GLP-1 receptor agonists (such as semaglutide and liraglutide) and dual GLP-1/GIP agonists (such as tirzepatide): originally developed for diabetes and obesity, these medicines produce significant weight loss and improve metabolic health, and clinical trials show improvement in liver fat and inflammation.
• Resmetirom: a thyroid hormone receptor-beta agonist, which became the first medicine approved specifically for non-cirrhotic NASH with significant fibrosis in some countries. Availability differs by country.
• Other medicines, including SGLT2 inhibitors used in diabetes, are being studied for their effects on the liver.

Decisions about medication depend on the stage of liver disease, other conditions, side effects, and what is available where you are treated. Vitamin or antioxidant supplements should not be started without medical advice, as some can interact with other treatments.

Bariatric (weight-loss) surgery

For people with obesity that has not responded to other measures, bariatric surgery (such as sleeve gastrectomy or gastric bypass) can lead to substantial and sustained weight loss. Studies show this often improves NAFLD, reduces inflammation, and can lessen fibrosis. The decision is made jointly by a hepatologist, a bariatric team, and the patient, and it depends on overall health and the stage of liver disease.

Procedures for advanced disease

When NAFLD has progressed to cirrhosis, additional procedures may be part of care:

• Endoscopy to look for and treat enlarged veins (varices) in the food pipe or stomach
• Imaging surveillance (usually ultrasound every six months, sometimes with blood markers) to screen for liver cancer
• Paracentesis to remove fluid build-up in the abdomen
• Procedures to manage portal hypertension when complications arise

Liver transplantation

For a small number of patients with end-stage liver disease or liver cancer arising from NAFLD, liver transplantation may be considered. NAFLD-related cirrhosis is now one of the leading reasons for liver transplantation worldwide. Most patients with NAFLD will never need transplantation, and the goal of long-term care is to prevent the disease from reaching that stage.

Lifestyle and Self-Management

Lifestyle is not a side note in NAFLD — it is the central treatment. The changes that help the liver are also the changes that protect the heart, improve blood sugar, and lower the risk of several cancers.

Diet

There is no single “NAFLD diet,” but research consistently supports a pattern that is plant-rich, lower in refined carbohydrates, and lower in ultra-processed foods. The Mediterranean dietary pattern is the most studied and is recommended by EASL and AASLD as a reasonable framework.

Practical principles include:

• Plenty of vegetables, fruits, whole grains, legumes, nuts, and seeds
• Olive oil and other unsaturated fats as the main cooking fats
• Fish and lean protein sources, with less red and processed meat
• Smaller portions of refined carbohydrates such as white rice, white bread, and pastries
• Cutting back sharply on sugar-sweetened drinks, including fruit juice and sweetened tea or coffee
• Limiting deep-fried foods, packaged snacks, and ultra-processed items
• Mindful portion sizes, particularly for energy-dense foods

Fructose, especially from sweetened drinks, has been linked to liver fat accumulation, and cutting back on it is one of the highest-yield single changes.

Alcohol

Even though NAFLD is not caused by alcohol, alcohol still stresses the liver and can speed up progression. Many specialists advise that people with NAFLD — especially those with NASH or fibrosis — avoid alcohol altogether or keep intake very low, with the specific recommendation tailored to the stage of disease.

Physical activity

Regular activity reduces liver fat even before significant weight is lost. A practical target supported by most guidelines is:

• At least 150–300 minutes of moderate-intensity activity each week (such as brisk walking, cycling, or swimming), or 75–150 minutes of more vigorous activity
• Two or more sessions of resistance or strength work each week
• Reducing long periods of sitting where possible

Activity counts even when it does not produce weight loss. Both aerobic exercise and resistance training have been shown to reduce liver fat.

Sleep, stress, and smoking

• Aim for regular, sufficient sleep. Poor sleep and untreated sleep apnoea worsen metabolic health.
• Chronic stress affects eating patterns and metabolism; building in regular ways to wind down can help.
• Smoking accelerates liver fibrosis and increases the risk of heart disease and liver cancer. Stopping smoking is one of the most useful steps for overall and liver health.

Coffee

Multiple studies suggest that regular coffee intake is associated with a lower risk of liver fibrosis in people with NAFLD. Unsweetened coffee is the version supported by evidence; adding large amounts of sugar or syrups undoes the benefit.

Vaccinations

People with chronic liver disease are usually advised to be vaccinated against hepatitis A and hepatitis B, and to keep up to date with annual influenza and other recommended vaccines, to protect the liver from additional injury.

Monitoring and Follow-Up

Because NAFLD is a long-term condition, regular follow-up is part of treatment. The frequency and type of monitoring depend on the stage of disease.

What monitoring usually involves

• Blood tests to check liver enzymes, blood sugar (HbA1c), cholesterol, and kidney function
• Non-invasive fibrosis scoring such as FIB-4 at intervals to track changes
• FibroScan or other elastography to monitor fat and stiffness, typically every one to three years depending on stage
• Review of weight, blood pressure, waist size, and lifestyle at each visit
• Medication review to make sure all treatments are still appropriate and safe for the liver

Surveillance in advanced disease

• Liver ultrasound every six months, often with blood tests such as alpha-fetoprotein (AFP), to screen for liver cancer
• Endoscopy at intervals to look for varices in the food pipe
• Closer monitoring of kidney function and nutrition

Most people with NAFLD do not develop serious liver complications. However, when NAFLD progresses, it can cause significant problems. Understanding these complications helps explain why monitoring matters.

Liver-related complications

• Cirrhosis: widespread liver scarring that affects how the liver works
• Portal hypertension: raised pressure in the vein system around the liver, which can cause enlarged veins (varices) that may bleed
• Ascites: fluid build-up in the abdomen
• Hepatic encephalopathy: confusion or drowsiness caused by toxins the liver can no longer clear well
• Hepatocellular carcinoma (HCC): primary liver cancer, which can develop in cirrhosis and, less often, in NASH without cirrhosis
• Liver failure: in advanced cirrhosis, the liver may no longer be able to meet the body’s needs

Beyond the liver

NAFLD is not only a liver condition. People with NAFLD have a higher risk of:

• Heart disease and stroke, which are in fact the leading causes of death in people with NAFLD
• Type 2 diabetes, if not already present
• Chronic kidney disease
• Certain cancers, including colorectal and breast cancer

This is why treatment focuses on the whole metabolic picture, not the liver alone.

Living with NAFLD

A diagnosis of NAFLD often brings with it a need to rethink daily habits. Many people find it helpful to think in terms of small, sustainable changes rather than dramatic short-term efforts.

Building habits that last

• Set realistic goals. Losing 0.5–1 kg a week over several months is usually more durable than rapid drops.
• Track what helps. A simple food and activity log can reveal patterns and triggers.
• Plan meals where possible. Eating out and ordering in frequently makes portion control and ingredient choice harder.
• Find activities you enjoy. The best exercise is the one you will continue.
• Involve your household. Cooking and eating habits change more easily when the family changes them together.

Emotional impact

A liver diagnosis can be unsettling, especially when it is unexpected. Some people feel guilt or self-blame, particularly when weight is part of the picture. NAFLD has many drivers — genetic, hormonal, environmental, and behavioural — and treatment works best in an environment of support rather than blame. If anxiety, low mood, or disordered eating becomes a problem, mental health support is part of good care.

Talking to family

Because NAFLD runs in families and shares risk factors with diabetes and heart disease, it can be useful to let close relatives know. They may benefit from their own check-ups for blood sugar, cholesterol, and weight.

Prevention of Progression

Once NAFLD is diagnosed, the focus shifts from preventing the disease to preventing it from getting worse. The same lifestyle and metabolic measures that treat NAFLD also slow or stop its progression.

Key strategies

• Steady weight loss if you are above a healthy weight, with a target of at least 7–10% if NASH or fibrosis is present
• Tight control of blood sugar, blood pressure, and cholesterol
• A consistent dietary pattern (such as Mediterranean) and regular physical activity
• Avoiding or strictly limiting alcohol
• Not smoking
• Avoiding unnecessary medicines, herbal products, and supplements that can stress the liver — always check with your doctor before starting anything new
• Keeping appointments for monitoring, even when you feel well

Most progression in NAFLD happens slowly over years. This means there is real opportunity to change the path of the disease, even after the diagnosis.

NAFLD in Children

NAFLD is now one of the most common chronic liver conditions in children, particularly where childhood obesity is rising. Paediatric NAFLD differs from the adult condition in several important ways, and care is usually led by a paediatric hepatologist or gastroenterologist together with the family doctor.

How it presents

Most children with NAFLD have no symptoms. The condition is often picked up when liver enzymes are checked during work-up for obesity, type 2 diabetes, or another concern. Some children describe vague tummy discomfort or tiredness.

Diagnosis and monitoring

Other causes of liver disease in children must be carefully ruled out before NAFLD is diagnosed, because conditions such as Wilson’s disease, viral hepatitis, and autoimmune liver disease can look similar. Non-invasive tests including ultrasound, blood markers, and FibroScan are increasingly used, with biopsy reserved for selected cases.

Treatment

• Gradual, healthy changes in eating patterns rather than restrictive diets
• Reducing sugary drinks, juice, and ultra-processed snacks
• Daily physical activity and reducing screen time
• Treating related conditions such as type 2 diabetes
• Support for the whole family rather than focusing on the child alone

Medication use is more limited in children than in adults and is decided by paediatric specialists. Bariatric surgery is considered only in selected adolescents with severe obesity within specialist programmes.

Long-term outlook

With consistent family-centred care, many children improve significantly. Because the disease starts so early, ongoing follow-up into adulthood is important.

When to Seek Urgent Care

People with NAFLD, particularly those with cirrhosis, should know which symptoms need urgent medical attention. Seek emergency care if you experience:

• Vomiting blood or material that looks like coffee grounds
• Passing black, tarry, or bloody stools
• Sudden, severe abdominal pain
• Marked confusion, severe drowsiness, or difficulty waking
• New or rapidly worsening jaundice
• Sudden swelling of the abdomen with breathlessness
• High fever in the setting of known cirrhosis

Contact your specialist team promptly — even if not as an emergency — if you notice new persistent fatigue, gradual swelling of the legs or abdomen, easy bruising, or unexplained weight loss.

Frequently Asked Questions

Can NAFLD be reversed?

In its early stages, simple fatty liver can often be reversed with sustained weight loss, better diet, and regular activity. Even with NASH or early fibrosis, inflammation can improve and some scarring can lessen. Once cirrhosis develops, the focus shifts to preventing further damage and complications rather than full reversal.

If I am not overweight, can I still have NAFLD?

Yes. A subset of people with NAFLD have a normal body mass index — sometimes called “lean NAFLD.” This is more common in South Asian populations and is still linked to insulin resistance, abdominal fat, and genetic factors. Management principles are similar, with attention to diet quality, activity, and metabolic health.

Is it safe to drink any alcohol with NAFLD?

Even small amounts of alcohol can stress an already fatty or inflamed liver. Many specialists advise people with NAFLD to avoid alcohol or keep intake very low, with stricter advice for those with NASH, significant fibrosis, or cirrhosis. The right limit for you is best decided with your doctor.

Will I need a liver biopsy?

Not necessarily. Non-invasive tests such as FIB-4, FibroScan, and MRI-based methods are now able to estimate fat and fibrosis well in most patients. Biopsy is used when the diagnosis is unclear, when another liver condition might overlap, or when more precise information is needed for treatment decisions.

Are herbal liver tonics or supplements helpful?

Most have not been shown to improve NAFLD, and some can actually harm the liver. Always tell your doctor about any herbal products, traditional remedies, or supplements you take. Decisions about vitamin E or other specific supplements should be made with a specialist.

Does NAFLD increase the risk of heart disease?

Yes. People with NAFLD share many risk factors with heart disease, and studies show a higher risk of heart attack and stroke. This is why care addresses cholesterol, blood pressure, blood sugar, and overall cardiovascular risk, not just the liver.

How often will I need check-ups?

This depends on the stage of disease. Many people with simple fatty liver are reviewed every one to two years. People with NASH or fibrosis are usually seen more often, and people with cirrhosis need regular surveillance, including six-monthly imaging for liver cancer. Your specialist will set a schedule that fits your situation.

Can NAFLD turn into liver cancer without cirrhosis?

Most NAFLD-related liver cancers occur in people with cirrhosis, but a smaller number occur in NASH without cirrhosis. This is one reason why staging and follow-up matter, even when the liver does not feel obviously sick.

Is there a cure?

There is no single cure for NAFLD, but the disease is highly treatable. With sustained lifestyle change, control of related conditions, and, where appropriate, medication, many people stabilise or improve their liver disease and live full lives. The earlier care begins, the more the liver can recover.

Conclusion

Non-alcoholic fatty liver disease is common, often silent, and deeply linked to the body’s overall metabolic health. For most people, it is a slow-moving condition that responds well to steady, well-supported changes: gradual weight loss, a healthier dietary pattern, regular activity, and careful control of diabetes, cholesterol, and blood pressure. For those with more advanced disease, specialist hepatology care — with non-invasive testing, structured monitoring, and treatment of complications — can preserve liver function and improve quality of life.

A NAFLD diagnosis is not a sentence on the liver. It is, in many ways, an early warning and an opportunity. With the right plan and consistent follow-up, the liver has a remarkable ability to recover and to keep doing its work for the rest of life.